Literature DB >> 9041081

Effect of myopic excimer laser photorefractive keratectomy on the electrophysiologic function of the retina and optic nerve.

L Spadea1, T Dragani, R Magni, G Rinaldi, E Balestrazzi.   

Abstract

PURPOSE: To assess by electrophysiologic testing the effect of photorefractive keratectomy (PRK) on the retina and optic nerve.
SETTING: Eye Clinic, S. Salvatore Hospital, L'Aquila University, Italy.
METHODS: Standard pattern electroretinograms (P-ERGs) and standard pattern visual evoked potentials (P-VEPs) were done in 25 eyes of 25 patients who had myopic PRK for an attempted correction between 5.00 and 15.00 diopters (D) (mean 8.00 D). Testing was done preoperatively and 3, 6, 12, and 18 months postoperatively. The contralateral eyes served as controls. During the follow-up, 3 patients (12%) developed steroid-induced elevated intraocular pressure (IOP) that resolved after corticosteroid therapy was discontinued.
RESULTS: No statistically significant differences were seen between treated and control eyes nor between treated eyes preoperatively and postoperatively.
CONCLUSION: Myopic excimer laser PRK did not seem to affect the posterior segment. The transient steroid-induced IOP rise did not seem to cause functional impairment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9041081     DOI: 10.1016/s0886-3350(96)80190-8

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  2 in total

1.  Evaluation of visual evoked potential binocular summation after corneal refractive surgery.

Authors:  Rasoul Amini Vishteh; Ali Mirzajani; Ebrahim Jafarzadehpur; Abolghasem Taghieh
Journal:  Doc Ophthalmol       Date:  2019-10-25       Impact factor: 2.379

2.  Correlations between visual morphological, electrophysiological, and acuity changes in chronic non-arteritic ischemic optic neuropathy.

Authors:  Lucilla Barbano; Lucia Ziccardi; Vincenzo Parisi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-07       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.